Aclaris Therapeutics ACRS
NASDAQ ACRS
$3.75 -0.08 (-2.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

Aclaris Therapeutics (ACRS) Sale and Maturity of Investments (2014 - 2026)

Updated

Analysis

Aclaris Therapeutics (ACRS) Sale and Maturity of Investments (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Aclaris Therapeutics 524.34 Mn 140.71 Mn 1.41 Mn 19.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.25 Mn
Mar 31, 2026 20.75 Mn
Dec 31, 2025 15.00 Mn
Sep 30, 2025 19.05 Mn
Jun 30, 2025 25.00 Mn
Mar 31, 2025 29.99 Mn
Dec 31, 2024 17.51 Mn
Sep 30, 2024 17.13 Mn
Jun 30, 2024 34.53 Mn
Mar 31, 2024 16.97 Mn
Dec 31, 2023 7.99 Mn
Sep 30, 2023 49.78 Mn
Jun 30, 2023 70.56 Mn
Mar 31, 2023 54.88 Mn
Dec 31, 2022 48.83 Mn
Sep 30, 2022 35.00 Mn
Jun 30, 2022 49.50 Mn
Mar 31, 2022 44.65 Mn
Dec 31, 2021 26.32 Mn
Sep 30, 2021 14.96 Mn
API Access

Aclaris Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEY